Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganshuang Keli for chronic hepatitis B and liver fibrosis
ChiCTR-TRC-13003726Phase 4Completed
- Sponsor
- PLA General Hospital Fifth Medical Center
- Start
- Sep 2013
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Ganshuang Keli in Chronic Hepatitis B (CHB) and hepatic fibrosis (2 arms), sponsored by PLA General Hospital Fifth Medical Center. Primary endpoints: Liver function indicators, Serum fibrosis index and 5 more. Started Sep 2013; status: completed.
02
Drugs
Ganshuang Keli
03
Conditions
Chronic Hepatitis B (CHB)hepatic fibrosis
Beyond the preview
Go deeper on ChiCTR-TRC-13003726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003726.